Targeting cytokines in inflammatory diseases: focus on interleukin-1-mediated autoinflammation

Abstract

In this commentary, we summarize the most recent advances in the cytokine-targeting therapies. We focus on new aspects of interleukin-1 (IL-1)-mediated autoinflammation and novel strategies to target IL-1. 
DOI: 10.3410/B1-70

Topics

2 Figures and Tables

Slides referencing similar topics